Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,050.00    25.00 (0.41%)
Bid:
6,045.00
Ask:
6,050.00
Spread: 5.00 (0.083%)
Market Cap: £5.17b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 8.3 - DCC Plc

22 May 2026 08:59

RNS Number : 4560F
Societe Generale SA
22 May 2026
 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

DCC PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

21/05/2026

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

€0.25 Ordinary Shares

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

226,368

0.26

978

0.00

(2) Cash-settled derivatives

5,634

0.01

56,775

0.07

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.00

0

0.00

Total

*233,884

0.27

57,753

0.07

 

*Include the holding of 1,882 shares on borrow products.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

 

 

 

 

 

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unitGBP (Note 5)

€0.25 Ordinary Shares

Purchase

1,798

61.1779

€0.25 Ordinary Shares

Purchase

2,697

61.0872

€0.25 Ordinary Shares

Purchase

9

61.25

€0.25 Ordinary Shares

Purchase

70

61.25

€0.25 Ordinary Shares

Purchase

171

61.25

€0.25 Ordinary Shares

Purchase

290

61.25

€0.25 Ordinary Shares

Purchase

360

61.25

€0.25 Ordinary Shares

Purchase

29

61.15

€0.25 Ordinary Shares

Purchase

67

61.15

€0.25 Ordinary Shares

Purchase

96

61.15

€0.25 Ordinary Shares

Purchase

6

61.25

€0.25 Ordinary Shares

Purchase

34

61.25

€0.25 Ordinary Shares

Purchase

34

61.25

€0.25 Ordinary Shares

Purchase

34

61.25

€0.25 Ordinary Shares

Purchase

34

61.25

€0.25 Ordinary Shares

Purchase

50

61.25

€0.25 Ordinary Shares

Purchase

99

61.25

€0.25 Ordinary Shares

Purchase

149

61.25

€0.25 Ordinary Shares

Purchase

312

61.25

€0.25 Ordinary Shares

Purchase

316

61.25

€0.25 Ordinary Shares

Purchase

326

61.25

€0.25 Ordinary Shares

Purchase

360

61.25

€0.25 Ordinary Shares

Purchase

360

61.25

€0.25 Ordinary Shares

Purchase

5

61.45

€0.25 Ordinary Shares

Purchase

2

61.45

€0.25 Ordinary Shares

Purchase

2

61.25

€0.25 Ordinary Shares

Purchase

2

61.45

€0.25 Ordinary Shares

Purchase

2

61.45

€0.25 Ordinary Shares

Purchase

7

61.45

€0.25 Ordinary Shares

Purchase

2

61.25

€0.25 Ordinary Shares

Purchase

2

61.25

€0.25 Ordinary Shares

Sale

195

61.24082

€0.25 Ordinary Shares

Sale

23

61.25

€0.25 Ordinary Shares

Sale

10

61.4

€0.25 Ordinary Shares

Sale

16

61.4

€0.25 Ordinary Shares

Sale

29

61.1

€0.25 Ordinary Shares

Sale

29

61.15

€0.25 Ordinary Shares

Sale

29

61.15

€0.25 Ordinary Shares

Sale

29

61.3

€0.25 Ordinary Shares

Sale

29

61.3

€0.25 Ordinary Shares

Sale

29

61.5

€0.25 Ordinary Shares

Sale

47

61.3

€0.25 Ordinary Shares

Sale

48

61.4

€0.25 Ordinary Shares

Sale

55

61.25

€0.25 Ordinary Shares

Sale

57

61.3

€0.25 Ordinary Shares

Sale

137

61.35

€0.25 Ordinary Shares

Sale

152

61.4

€0.25 Ordinary Shares

Sale

110

61.35

€0.25 Ordinary Shares

Sale

6

61.35

€0.25 Ordinary Shares

Sale

9

61.35

€0.25 Ordinary Shares

Sale

10

61.35

€0.25 Ordinary Shares

Sale

31

61.35

€0.25 Ordinary Shares

Sale

31

61.35

€0.25 Ordinary Shares

Sale

16

61.15

€0.25 Ordinary Shares

Sale

80

61.15

€0.25 Ordinary Shares

Sale

95

61.5

€0.25 Ordinary Shares

Sale

96

61.05

€0.25 Ordinary Shares

Sale

96

61.3

€0.25 Ordinary Shares

Sale

92

61.45

€0.25 Ordinary Shares

Sale

374,874

61

€0.25 Ordinary Shares

Sale

68,524

61

 

Ap29

(b) Cash-settled derivative transactions

 

Class ofrelevantsecurity

Product descriptione.g. CFD

Nature of dealinge.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number ofreferencesecurities(Note 6)

Price per unit GBP(Note 5)

€0.25 Ordinary Shares

CFD

Increasing a long position

195

61.24082

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

NO

 

Date of disclosure

22/05/2026

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

Ap31

 

NOTES ON FORM 8.3

 

1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. See Rule 2.5(d) of Part A of the Rules.

 

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPPPUMAAUPQUMP
Date   Source Headline
23rd May 20255:10 pmRNSDirector/PDMR Shareholding
13th May 20257:00 amRNSResults for the year ended 31 March 2025
22nd Apr 20257:00 amRNSDisposal of DCC Healthcare
9th Apr 20257:00 amRNSDCC Leadership Changes
28th Feb 202511:00 amRNSTotal Voting Rights
5th Feb 20257:00 amRNSQ3 Trading Statement
9th Dec 202412:23 pmRNSDirector Declaration
29th Nov 20242:33 pmRNSTotal Voting Rights
18th Nov 20245:30 pmRNSDirector/PDMR Shareholding
12th Nov 20247:01 amRNSResults for the six months ended 30 September 2024
12th Nov 20247:00 amRNSStrategy Update: DCC to focus on Energy sector
20th Aug 20245:52 pmRNSHolding in Company TR-1
31st Jul 20242:20 pmRNSTotal Voting Rights
11th Jul 20244:53 pmRNSResult of AGM
11th Jul 20247:02 amRNSBoard Appointment
11th Jul 20247:01 amRNSDivestment of Hong Kong Energy Business
11th Jul 20247:00 amRNSAGM Trading Statement
12th Jun 202410:09 amRNS2024 Sustainability Report
12th Jun 202410:05 amRNS2024 Annual Report, Notice of AGM and Proxy Form
31st May 20245:00 pmRNSDirector/PDMR Shareholding
31st May 20244:30 pmRNSTotal Voting Rights
24th May 20245:00 pmRNSDirector/PDMR Shareholding
14th May 20247:00 amRNSResults for the year ended 31 March 2024
6th Mar 20244:52 pmRNSHolding in Company
28th Feb 20243:52 pmRNSTotal Voting Rights
7th Feb 20247:00 amRNSInterim Management Statement
31st Jan 20249:44 amRNSTotal Voting Rights
14th Dec 20237:00 amRNSBoard and Remuneration Committee Changes
30th Nov 202311:59 amRNSTotal Voting Rights
24th Nov 20235:34 pmRNSDirector/PDMR Shareholding
20th Nov 20235:45 pmRNSDirector/PDMR Shareholding
14th Nov 20237:01 amRNSAcquisition of Progas GmbH
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
6th Sep 20237:00 amRNSDCC Energy Insights Day and Five New Acquisitions
31st Jul 20231:03 pmRNSTotal Voting Rights
13th Jul 20235:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSAGM Trading Statement
14th Jun 202310:09 amRNS2023 Sustainability Report
14th Jun 202310:05 amRNS2023 Annual Report, Notice of AGM and Proxy Form
31st May 20234:38 pmRNSTotal Voting Rights
26th May 20234:58 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSResults for the year ended 31 March 2023
9th May 20237:00 amRNSStatement regarding Chief Executive
25th Apr 20237:00 amRNSNotice of Full Year 2023 Results
28th Feb 20239:36 amRNSTotal Voting Rights
8th Feb 20237:00 amRNSBoard Appointment
8th Feb 20237:00 amRNSInterim Management Statement
6th Jan 20235:39 pmRNSHolding in Company TR-1
30th Nov 20223:28 pmRNSTotal Voting Rights
14th Nov 20225:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.